Norepinephrine Bitartrate (Nevakar Injectables)

重酒石酸去甲肾上腺素 (Nevakar Injectables)

Report date: 2025/05/16 20:00:39

Base Information

Drug NameNorepinephrine Bitartrate (Nevakar Injectables)
Drug Alias NamePremix Norepinephrine Bitartrate重酒石酸去甲肾上腺素 0.9% 氯化钠注射液Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection
ClassificationSmall molecules
Mechanisms of ActionAlpha-1a adrenergic receptor agonistsAlpha-1b adrenergic receptor agonists
TargetsAlpha-1a adrenergic receptorAlpha-1b adrenergic receptor
Therapy Area/IndicationsHypotension
Global Approved IndicationsHypotension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/10/06
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNevakar Injectables Inc
China Registration ClassN/A

Develop Information

Active CompaniesLong Grove Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsHypotension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A